Application Information

This drug has been submitted to the FDA under the reference 010976/007.

Names and composition

"ENOVID-E 21" is the commercial name of a drug composed of MESTRANOL and NORETHYNODREL.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
010976/007 ENOVID-E 21 MESTRANOL; NORETHYNODREL TABLET/ORAL-21 0.1MG and 2.5MG

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
010976/004 ENOVID MESTRANOL; NORETHYNODREL TABLET/ORAL-20 0.075MG and 5MG
010976/005 ENOVID MESTRANOL; NORETHYNODREL TABLET/ORAL 0.15MG and 9.85MG
010976/006 ENOVID-E MESTRANOL; NORETHYNODREL TABLET/ORAL-20 0.1MG and 2.5MG
010976/007 ENOVID-E 21 MESTRANOL; NORETHYNODREL TABLET/ORAL-21 0.1MG and 2.5MG
010976/008 ENOVID MESTRANOL; NORETHYNODREL TABLET/ORAL 0.075MG and 5MG

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved